The full form of HPC in medical term is “Haematopoietic Progenitor Cell (HPC) Count.”
The human body’s blood-forming process greatly depends on Haematopoietic Progenitor Cells (HPCs). These bone marrow-located cells produce all the various blood cell types, including white blood cells, red blood cells, and platelets. The HPC count is a crucial parameter used in clinical practice and medical research to evaluate a patient’s blood-forming system’s health.
The HPC count is often evaluated by flow cytometry, which involves staining blood or bone marrow specimens with particular antibodies that bind to HPCs. After staining, the cells are sent through a flow cytometer that utilizes lasers to determine the quantity and presence of every cell type.
Lymphoma, Leukemia, and aplastic anemia are just a few of the various blood illnesses that can be diagnosed and treated with the help of the HPC count.
The HPC count is a vital instrument used in clinical practice and medical research to evaluate the condition of the blood-forming system. The HPC count is utilized in bone marrow transplantation to diagnose blood diseases. The HPC count is additionally used in research to examine how various therapies affect the system that forms blood.